Loading...

joneselena's Recent CancerCompass Activity

  • joneselena has created a new message board discussion

    Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders. For more information please use the contact details below.  Phone: +1 (406) 272-7824 e...

    August 23 at 3:50 PM view discussion
    • joneselena has created a new message board discussion

      Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders. For more information please use the contact details below.  Phone: +1 (406) 272-7824 e...

      August 23 at 3:49 PM view discussion
      • joneselena has created a new message board discussion

        Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly  used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders. For more information please use the contact details below.  Phone: +1 (406) 272-7...

        August 20 at 7:21 AM view discussion
        • joneselena has created a new message board discussion

          Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly  used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders. For more information please use the contact details below.  Phone: +1 (406) 272-7...

          August 20 at 7:20 AM view discussion
          • joneselena has created a new message board discussion

            Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly  used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders. For more information please use the contact details below.  Phone: +1 (406) 272-7...

            August 20 at 7:19 AM view discussion
            • joneselena has created a new message board discussion

              Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly  used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders. For more information please use the contact details below.  Phone: +1 (406) 272-7...

              August 20 at 12:15 AM view discussion
              • joneselena has created a new message board discussion

                Revlimid (lenalidomide) is a member of the miscellaneous antineoplastics drug class and is commonly  used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders. For more information please use the contact details below.  Phone: +1 (406) 272-7...

                August 20 at 12:13 AM view discussion
                Loading...
                Load more activity
                Loading more activity

                About joneselena

                joneselena has not shared any information about themselves. Send them a message to tell them you'd like to find out more about them or add them as a friend.

                We care about your feedback. Let us know how we can improve your CancerCompass experience.